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AbstrAct
The objectives of this study were fourfold: technical 
validation of a commercial canine 1,2-o-dilauryl-rac-
glycero glutaric acid-(6’-methylresorufin) ester (DGGR) 
lipase assay, to calculate a reference interval for DGGR 
lipase by the indirect a posteriori method, to establish 
biological validity of the assay, and to assess agreement 
between DGGR lipase and specific canine pancreatic lipase 
(Spec cPL) assays. Dogs with histologically confirmed 
acute pancreatitis (n=3), chronic pancreatitis (n=8) and 
normal pancreatic tissue (n=7) with stored (−80°C) serum 
samples were identified. Relevant controls were selected. 
Precision, reproducibility and linearity of DGGR lipase, 
and the effect of sample haemolysis and freezing, were 
assessed. Sensitivity and specificity of DGGR lipase and 
Spec cPL were determined. Agreement between these 
two parameters was calculated using Cohen’s kappa 
coefficient (κ). The DGGR lipase assay demonstrated 
excellent precision, reproducibility and linearity. Sample 
haemolysis and storage at −80°C for 12 months did 
not influence the assay. DGGR lipase (>245IU/l) and 
Spec cPL (>400µg/l) both showed poor sensitivity but 
excellent specificity for acute pancreatitis, and poor to 
moderate sensitivity but excellent specificity for chronic 
pancreatitis. Substantial agreement (κ=0.679) was found 
between DGGR lipase and Spec cPL. The validated DGGR 
lipase assay had similar sensitivity and specificity for the 
diagnosis of acute and chronic pancreatitis to Spec cPL. 
DGGR lipase is a reliable alternative to Spec cPL for the 
diagnosis of pancreatitis.
IntroduCtIon
Pancreatitis is a common condition which 
can vary widely in presentation. Disease can 
range from mild and subclinical, to acute, 
necrotising and fatal. Clinical signs are often 
non-specific, including vomiting, diarrhoea, 
lethargy, anorexia and weight loss, making 
a definitive diagnosis challenging. Histolog-
ically, acute cases show peripancreatic fat 
necrosis, oedema and neutrophil infiltration. 
Chronic cases show fibrosis with mononuclear 
cell infiltrate and acinar cell loss.1 However, 
acute-on-chronic disease can also occur.
The current gold standard for the diag-
nosis of pancreatitis is surgical biopsy and 
histology.2 3 However, this method is invasive,4 
costly and impractical to perform on all cases 
with suspected disease. The most commonly 
used diagnostic method is measurement of 
circulating markers of pancreatic inflam-
mation in the blood. However, no currently 
available blood test for pancreatitis demon-
strates 100 per cent accuracy. The specific 
canine pancreatic lipase (Spec cPL) immu-
noreactivity is regarded as the most sensitive 
(71 per cent in moderate-severe cases) and 
specific (86–100 per cent) test available.5 
However it is costly and has a relatively long 
turnaround time (two to three days). An 
immediate kennel-side SNAP test is available, 
but is not quantitative and has low specificity 
(59 per cent).6 Catalytic (1,2-diglyceride) 
lipase assays are quantitative, cheap and quick, 
but are not organ-specific (with specificity 
of approximately 43 per cent in moderate to 
severe cases).5 The need remains for a sensi-
tive, specific, non-invasive test for pancreatitis 
which can provide quick diagnostic results.
In 2001 a new catalytic lipase assay, 
using 1,2-o-dilauryl-rac-glycero glutaric 
acid-(6’-methylresorufin) ester (DGGR) as 
substrate, was introduced, and validated 
in 2005 for use in dogs.7 The enzyme and 
substrate interactions are reported to be more 
selective than previously used lipase assays, so 
it is suggested that hydrolysis with extrapan-
creatic lipases and esterases is less likely to 
occur. The DGGR assay is therefore proposed 
to be more specific than the traditional lipase 
assays such as the 1,2-diglyceride assay.
DGGR lipase is cheaper to perform than 
Spec cPL and the results can be available 
within one hour of arrival of the sample at 
many commercial laboratories. Studies have 
shown good agreement between the Spec cPL 
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and DGGR lipase assay,8 9 and fair agreement between the 
DGGR lipase assay and an ultrasonographic diagnosis of 
pancreatitis.10 No studies to date have specifically investi-
gated the agreement of DGGR lipase with a histological 
diagnosis of pancreatitis in dogs, despite this being the 
gold standard for the diagnosis of pancreatitis.
The aims of this study were first to perform technical 
validation of a novel DGGR lipase assay for use in canine 
serum, secondly to calculate a reference interval for 
DGGR lipase by the indirect a posteriori method, thirdly 
to perform biological validation of this assay by assessing 
the sensitivity and specificity of DGGR lipase for the diag-
nosis of acute and chronic pancreatitis, and fourthly to 
verify the agreement of this DGGR lipase assay with Spec 
cPL.
MaterIals and Methods
Measurement and technical validation of dGGr lipase
DGGR lipase activity was measured using a commer-
cially available assay (DiaSys Lipase DC FS, Holzheim, 
Germany). For technical validation purposes, samples 
with DGGR lipase greater than 300IU/l were excluded 
as these exceeded the upper end of the linear range 
of the assay. Precision and repeatability were assessed 
by evaluating intra-assay and interassay coefficients of 
variation (CV) for serum samples with low and medium 
serum DGGR lipase activities (approximately 100IU/l 
and 250IU/l). For intra-assay precision, three repli-
cates of each sample were evaluated within the same 
run. For assessment of interassay variability, pooled 
canine serum samples were evaluated in duplicate on 
three consecutive working days. Linearity was eval-
uated using canine serum pools of medium and low 
DGGR lipase activities (250IU/l and 100IU/l), with 
dilution samples prepared by mixing the medium and 
low pooled samples in different proportions. The line-
arity was determined by comparing the observed DGGR 
lipase activity following dilution with the expected 
(calculated) DGGR lipase activity. Linearity following 
dilution of a sample with medium DGGR lipase activity 
(approximately 250UI/l) with saline was also deter-
mined. Stability of the photometrically determined 
DGGR lipase after 12 months of storage at −80°C was 
also assessed. Interference by haemolysis was deter-
mined by addition of canine blood haemolysate to 
canine serum samples. The haemolysate was prepared 
by washing of canine erythrocytes three times in 
saline, before lysis of the erythrocytes by addition of 
double distilled water (diH2O). The haemolysate was 
sequentially added to the serum samples, with the 
final haemoglobin concentration of the serum deter-
mined grossly and photometrically. Four samples with 
different haemoglobin concentrations (0g/l, 1g/l, 
2g/l and 4g/l) were obtained. Expected DGGR lipase 
activity was calculated and compared with the observed 
DGGR lipase activity in order to evaluate the influence 
of the haemolysis on the DGGR lipase measurement.
Construction of a reference interval for dGGr lipase by the a 
posteriori method
In order to calculate a reference interval for DGGR 
lipase by the indirect a posteriori method,11 all dogs that 
had DGGR lipase activity measured by the Central Diag-
nostic Services between January  1, 2015 and December 
31, 2015 were retrospectively evaluated. Cases with a 
clinical history of pancreatitis, gastrointestinal disease or 
thromboembolic disease, those with abnormal cardiac 
auscultation or congestive heart failure, those with docu-
mented azotaemia (elevated serum urea and/or creati-
nine concentrations), and cases treated with corticos-
teroids were excluded. The remaining cases were then 
used to construct a reference interval using computer-
ised software (Reference Value Advisor V.2.1; http://
www. biostat. envt. fr/ spip/ spip. php? article63),12 which 
calculated the lower and upper limits of the DGGR lipase 
reference interval by the robust method using Box-Cox 
transformed data.
Biological validation of dGGr lipase in dogs with acute and 
chronic pancreatitis and controls
For the biological validation, the pathology database of 
the authors’ institution was searched to identify dogs 
between 2008 and 2015 with a histological diagnosis 
of acute pancreatitis, chronic pancreatitis and normal 
pancreatic tissue. Normal cases were selected based on 
documentation of clinical signs for which pancreatitis was 
a differential diagnosis (eg, vomiting, diarrhoea, abdom-
inal pain). Histological slides of either postmortem 
sections or surgical biopsies from these cases were 
reviewed by one pathologist to confirm disease status 
(acute or chronic pancreatitis, or normal). Histological 
samples were categorised as acute pancreatitis given the 
predominance of neutrophils, fat necrosis and oedema, 
whereas samples were categorised as chronic pancreatitis 
if there were fibrosis and lymphocytic infiltrate. Serum 
samples (stored at −80°C) taken within 24 days of the time 
of tissue sampling were used for measurement of DGGR 
lipase and Spec cPL. Cases were excluded if biochemistry 
results indicated azotaemia, because reduced glomerular 
filtration rate may falsely elevate serum lipase measure-
ments due to reduced renal clearance of the enzyme.13 14 
DGGR lipase activity was measured using the validated 
DGGR lipase assay in the authors’ laboratory. Spec cPL 
was measured by IDEXX Laboratories (Wetherby, UK).
statistical analysis
Statistical analysis was performed using commercial soft-
ware (SPSS V.21, IBM). Data are presented as median 
(25th and 75th percentile). Sensitivity and specificity 
(plus 95 per cent confidence intervals (CI)) of both the 
Spec cPL and DGGR lipase for a diagnosis of either acute 
or chronic pancreatitis were calculated. Correlations were 
assessed using Spearman’s correlation coefficient. Agree-
ment between the two assays was assessed using Cohen’s 
kappa coefficient (κ). κ values indicate the following 
agreement: <0=no agreement; 0–0.20=slight agreement; 
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0.21–0.4=fair agreement; 0.41–0.60 moderate agree-
ment; 0.61–0.8=substantial agreement; and 0.81–
1.0=almost perfect agreement.
results
technical validation
Interassay precision for samples containing medium 
and low lipase activities (CV=0.3 per cent and 
1.1 per cent, respectively) and intra-assay precision 
for samples containing medium and low lipase activ-
ities (CV=0.7 per cent and 0.9 per cent, respectively) 
were excellent. Following dilution of serum of medium 
lipase activity with serum of low lipase activity, the assay 
was linear in the range of 51–246nmol/l (r2=0.998) 
with acceptable analyte recovery (<5.3 per cent devi-
ation from calculated value at any point). Dilution of 
serum with medium lipase activity with saline was linear 
(r2=0.999); however, a matrix effect was evident. Storage 
of serum at −80°C for 12 months did not result in a signif-
icant change in DGGR lipase activity (61 (82, 102) IU/l 
(median (25th, 75th percentile)) versus 86 (107, 132)
IU/l, n=12; P=0.209). Haemolysis of the sample up to 
8g/l (consistent with 3+ haemolysis grossly) did not result 
in significant changes to the lipase activity.
dGGr reference interval
Thirty-seven dogs were eligible for inclusion in the popu-
lation of dogs used to construct the DGGR reference 
interval. Sixteen dogs had neurological disease, six cases 
had orthopaedic disease, five had inflammatory diseases 
(non-gastrointestinal), four had neoplastic diseases, four 
had respiratory disease, one had urolithiasis and one had 
dermatological disease. The calculated reference interval 
for DGGR lipase was 23–245IU/l.
Biological validation
Eighteen dogs were included in the biological valida-
tion study. Three dogs had histologically confirmed 
acute pancreatitis, eight had histologically confirmed 
chronic pancreatitis and seven control dogs (with clinical 
signs compatible with pancreatitis) had normal pancre-
atic tissue (six at postmortem examination and one on 
pancreatic biopsy). Signalment and the time between 
serum and tissue sampling in these cases are shown in 
Table 1. The maximum time between blood and tissue 
sampling was 24 days; however, the DGGR lipase and 
Spec cPL values for this case were 380IU/l and 374µg/l, 
respectively.
DGGR lipase for dogs with histologically normal 
pancreatic tissue was 61 (43, 138IU/l), and for cases 
diagnosed with chronic pancreatitis on histology was 173 
(62, 435IU/l). DGGR lipase values in cases with acute 
pancreatitis were 106IU/l, 195IU/l and 233IU/L. The 
DGGR lipase activities in all three acute cases were within 
the calculated DGGR lipase reference interval. Spec cPL 
for dogs with histologically normal pancreatic tissue was 
53µg/l (36, 169µg/l); for dogs with chronic pancreatitis 
was 217µg/l (42, 509µg/l), and in the three dogs with 
acute pancreatitis Spec cPL concentrations were 98µg/l, 
375µg/l and 642µg/l.
DGGR lipase greater than 245IU/l was 0 per cent 
(95 per cent CI 0–69 per cent) sensitive and 100 per cent 
(95 per cent CI 56–100 per cent) specific for acute pancre-
atitis. Spec cPL concentration greater than 400µg/l was 
33 per cent (95 per cent CI 18–87 per cent) sensitive and 
100 per cent (95 per cent CI 56–100 per cent) specific for 
acute pancreatitis.
DGGR lipase greater than 245IU/l was 57 per cent 
(95 per cent CI 20–88 per cent) sensitive and 100 per cent 
(95 per cent CI 56–100 per cent) specific for chronic 
pancreatitis. Spec cPL concentration greater than 400µg/l 
was 42 per cent (95 per cent CI 12–80 per cent) sensi-
tive and 100 per cent (95 per cent CI 56–100 per cent) 
specific for chronic pancreatitis. DGGR lipase and Spec 
cPL were highly correlated (rs=0.925, n=18; P<0.001). 
Agreement analysis indicated that DGGR lipase greater 
than 245IU/l and Spec cPL greater than 400 µg/l had 
substantial agreement (κ=0.679).
dIsCussIon
The results of this study indicate that the validated DGGR 
lipase assay demonstrates excellent precision and repro-
ducibility. The DGGR lipase assay appeared to be unaf-
fected by sample haemolysis, and DGGR lipase activity 
was not significantly different after 12 months of storage 
at −80°C. DGGR lipase and Spec cPL showed excellent 
agreement and had similar sensitivity and specificity for 
diagnoses of histologically confirmed acute and chronic 
pancreatitis.
The control dogs used were a relevant population 
because they presented with similar clinical signs to the 
cases of histologically confirmed pancreatitis, resulting in 
a more representative comparison that is faced by practi-
tioners than if normal healthy animals had been used as 
the control group.
Two acute cases in this study had DGGR lipase activity 
and Spec cPL values within reference intervals. An expla-
nation for the observed low sensitivity of DGGR lipase 
(and Spec cPL) for the diagnosis of chronic pancreatitis 
could be that the inflammation was mild in the cases that 
the authors included. It would have been useful, and 
a consideration for future studies, to utilise a histolog-
ical grading system to further classify cases into severe, 
moderate or mildly affected. Another explanation could 
be the delay between histological confirmation of disease 
and sampling. The sensitivities of DGGR lipase and Spec 
cPL were higher for chronic pancreatitis where persistent 
elevations of enzymes might be expected.
DGGR lipase and Spec cPL were measured using 
serum samples taken as close to the time of pancreatic 
biopsy or postmortem examination as possible in order 
to obtain representative serum lipase activities while the 
patient was still clinically affected. One of the chronic 
cases had the blood sample taken 24 days before the 
postmortem examination took place, and an acute case 
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had a 16-day period between blood sample and post-
mortem examination. Considering the serum half-life of 
canine lipase is thought to be relatively short (approxi-
mately two hours), it is likely that in some cases the serum 
lipase activity may not have correlated as well with the 
lesions observed on histology. However, blood samples 
were taken at, or around, the time that the animal 
presented with clinical signs. It is therefore likely that 
the lipase activity was representative of the presence or 
absence of pancreatic inflammation at the time of clin-
ical presentation. One would expect histological changes 
associated with pancreatitis to be present for some time 
after the initial disease insult, particularly in chronic cases 
where histological changes are permanent. Inclusion of 
these cases was therefore deemed justifiable.
DGGR has been considered to be more pancreas-spe-
cific than previously used lipase assays. However, a recent 
preliminary study found normal DGGR lipase activities 
in dogs with exocrine pancreatic insufficiency.15 This 
suggests DGGR may not be exclusively hydrolysed by 
pancreatic lipase; however, despite this, DGGR lipase was 
highly specific for pancreatitis in the present study. More 
studies are required to investigate these findings further, 
and DGGR is still likely to be more specific than the previ-
ously used 1,2-diglyceride assay.
The main limitation of the biological validation study 
was the small number of cases that were included, which 
was a result of the criteria required for case selection. 
Although the number of cases included in this study was 
low, the control dogs used were a relevant population 
TABLE1: Raw data of the results of DGGR lipase and Spec cPL assays for cases of histologically confirmed acute and 
chronic pancreatitis, and control animals, including signalment and time difference between blood sampling and biopsy or 
postmortem examination
Age (years) Sex Breed DGGR lipase (IU/l) Spec cPL (μg/l)
Time of blood sample 
relative to tissue 
sample (days)
Acute
10 MN Crossbreed 195.4 642 16 before 
postmortem examination
10 FN Crossbreed 233.3 375 1 after biopsy
5 MN Springer Spaniel 106 98 3 before biopsy
Chronic
12 FN Border terrier 73.1 42 1 after biopsy
3.25 MN Labradoodle 61.2 30 1 after biopsy
11 FN Chihuahua 61.3 59 7 after biopsy
9 FN Great dane x whippet 273.2 411 7 before 
postmortem examination
4 FN Crossbreed 63.2 43 2 after biopsy
11 FN Cocker Spaniel 454.2 541 15 after biopsy
12.8 FN Jack Russell terrier 379.5 374 24 before 
postmortem examination
7 MN Cocker Spaniel 1119 939 1 before biopsy
Control
12 FE Cavalier King Charles Spaniel 84.4 62 11 days before biopsy
7.5 ME Hungarian Vizsla 156.7 169 2 days before 
postmortem examination
12 MN English pointer 60.2 36 Same day as 
postmortem examination
0.25 FE Labrador retriever 42.3 38 6 days before 
postmortem examination
8 FN Maltese terrier 61 53 1 day before 
postmortem examination
6 MN Golden retriever 138.2 190 Same day as 
postmortem examination
6 MN Labrador retriever 43 30 6 days before 
postmortem examination
DGGR, 1,2-o-dilauryl-rac-glycero glutaric acid-(6’-methylresorufin) ester; FE, female entire; FN, female neutered; ME, male entire; MN, male 
neutered; Spec cPL, specific canine pancreatic lipase.  o
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because they presented with similar clinical signs to the 
cases of histologically confirmed pancreatitis, resulting 
in a more representative comparison that is faced by 
practitioners than if normal healthy animals had been 
used as the control group. However, further studies 
with higher number of cases are warranted to verify and 
strengthen these findings.
In conclusion, the results of this small, preliminary 
study indicate that the DGGR lipase assay may be used 
as a reliable alternative to Spec cPL in the diagnostic 
work-up of cases with suspected pancreatitis. This is 
suggested by the similar sensitivity and specificity found 
for the two assays for a diagnosis of acute and chronic 
pancreatitis, alongside the substantial agreement 
demonstrated.
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